Counterforce Health (Page 9)

More issues

Oxbryta (Voxelotor) Coverage by UnitedHealthcare in Pennsylvania: 2024 FDA Withdrawal Impact and Alternative Treatments

Answer Box: Oxbryta Coverage Status Oxbryta (voxelotor) was withdrawn from the U.S. market on September 25, 2024, following FDA safety concerns. UnitedHealthcare and all insurers now universally deny coverage—no appeals process exists for a withdrawn drug. If you were taking Oxbryta, contact your sickle cell specialist immediately to

Resources to Get Vyondys 53 (golodirsen) Approved with UnitedHealthcare in Washington: Forms, Portals & Contacts

Answer Box: Getting Vyondys 53 Covered by UnitedHealthcare in Washington Quick Path to Approval: UnitedHealthcare requires prior authorization for Vyondys 53 (golodirsen) with strict genetic documentation and ambulatory status requirements. Submit through the UnitedHealthcare Provider Portal with complete DMD genetic testing, functional assessments (NSAA >17 or TTR <7

How to Get Tracleer (bosentan) Covered by Aetna CVS Health in Pennsylvania: Complete Prior Authorization Guide

Answer Box: Getting Tracleer (bosentan) Covered by Aetna CVS Health in Pennsylvania Tracleer (bosentan) is typically non-formulary on Aetna's 2025 commercial plans, requiring prior authorization and step therapy with preferred alternatives like ambrisentan or Opsumit. All patients must enroll in the mandatory REMS program before dispensing. In Pennsylvania,

Work With Your Doctor to Get Tagrisso (Osimertinib) Approved by UnitedHealthcare in Florida: Prior Authorization Guide

Answer Box: Getting Tagrisso Approved by UnitedHealthcare in Florida Tagrisso (osimertinib) requires prior authorization from UnitedHealthcare for all members. To get approved, you need documented EGFR mutation testing (exon 19 deletion or L858R) and your oncologist must submit a complete prior authorization through the UnitedHealthcare Provider Portal. First step today:

How to Get Breyanzi Covered by UnitedHealthcare in Washington: Renewal Guide, Forms & Appeal Scripts

Answer Box: Renewing Breyanzi Coverage with UnitedHealthcare in Washington Renewing Breyanzi (lisocabtagene maraleucel) coverage with UnitedHealthcare requires submitting updated clinical documentation 30-60 days before your current authorization expires. Key steps: (1) Gather current labs, imaging, and physician letter documenting ongoing response, (2) Submit via UnitedHealthcare Provider Portal with all required

How to Get Koselugo (Selumetinib) Covered by Humana in Ohio: Complete Appeals Guide

Answer Box: Getting Koselugo Covered by Humana in Ohio Koselugo (selumetinib) requires prior authorization from Humana for pediatric NF1 patients with symptomatic, inoperable plexiform neurofibromas. Your fastest path to approval: (1) Have your specialist complete Humana's PA form with NF1 diagnosis confirmation, imaging showing inoperable PN, and baseline

How to Get Jynarque (Tolvaptan) Covered by Cigna in Michigan: Complete PA Guide with Forms and Appeal Scripts

Answer Box: Getting Jynarque Covered by Cigna in Michigan Jynarque (tolvaptan) requires prior authorization through Cigna and is typically covered as a Tier 4 specialty medication with step therapy requirements. To get approved in Michigan: 1. Document rapid ADPKD progression (Mayo Class 1C-1E or eGFR decline ≥3 mL/min/1.

How to Get Bylvay (Odevixibat) Covered by Cigna in California: Complete Prior Authorization and Appeals Guide

Answer Box: Get Bylvay (Odevixibat) Covered by Cigna in California Cigna requires prior authorization for Bylvay (odevixibat) for PFIC and Alagille syndrome patients. To get approved: (1) Submit PA through your specialist with genetic testing, treatment history, and weight-based dosing documentation via Accredo specialty pharmacy, (2) If denied, file internal

How to Get Tracleer (bosentan) Covered by Cigna in Illinois: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Tracleer (bosentan) Covered by Cigna in Illinois Cigna requires prior authorization for Tracleer (bosentan) with specific requirements including REMS enrollment, step therapy documentation, and monthly monitoring. The fastest path to approval: 1. Enroll in REMS program - Both prescriber and patient must register before submission 2. Document

Resources to Get Hetlioz (Tasimelteon) Approved with Blue Cross Blue Shield in Georgia: Forms, Portals & Appeals Guide

Answer Box: Getting Hetlioz Covered in Georgia Blue Cross Blue Shield of Georgia requires prior authorization for Hetlioz (tasimelteon) with strict documentation for Smith-Magenis syndrome (ages 3-15) or Non-24-Hour Sleep-Wake Disorder in totally blind adults. Start today: Gather genetic testing results, sleep disorder documentation, and contact HETLIOZSolutions® at 1-844-438-5469 for